ArticleThe Journal of investigative dermatology2015
SASH1 Is Involved in an Autosomal Dominant Lentiginous Phenotype.
Abstract readLetter
In one paragraph
Article in The Journal of investigative dermatology, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers.
0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed
–field-weighted citation impact
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
17 citing papers in PubMed.
- SASH1 as a Context-Dependent Multi-Docking Scaffold Linking Receptor Signaling to Cytoskeletal Dynamics.International journal of molecular sciences · 2026Review
- Genetic Pigmentary Disorders: From Molecular Mechanisms to Clinical Manifestations.The Journal of dermatology · 2026Review
- Dyschromatosis universalis hereditaria withSkin health and disease · 2025Review
- SASH1 S519N Variant Links Skin Hyperpigmentation and Premature Hair Graying to Dysfunction of Melanocyte Lineage.The Journal of investigative dermatology · 2025Article
- Case report: Clinicopathological characteristics ofFrontiers in genetics · 2025Article
- Solution NMR backbone assignment of the SASH1 SLy proteins associated disordered region (SPIDER).Biomolecular NMR assignments · 2023Article
- The Structural Dynamics, Complexity of Interactions, and Functions in Cancer of Multi-SAM Containing Proteins.Cancers · 2023Review
- The PER3Journal of molecular medicine (Berlin, Germany) · 2023Article
- SAM1 domain of SASH1 harbors distinctive structural heterogeneity.Journal of structural biology · 2022Article
- Novel missense mutation of SASH1 in a Chinese family with dyschromatosis universalis hereditaria.BMC medical genomics · 2021Article
- Two novel SASH1 mutations in Chinese families with dyschromatosis universalis hereditaria.Journal of clinical laboratory analysis · 2021Article
- Mutated SASH1 promotes Mitf expression in a heterozygous mutated SASH1 knock‑in mouse model.International journal of molecular medicine · 2020Article
- Identification of a Novel Mutation inFrontiers in genetics · 2020Article
- SASH1 promotes melanin synthesis and migration via suppression of TGF-β1 secretion in melanocytes resulting in pathologic hyperpigmentation.International journal of biological sciences · 2020Article
- The Tumor Suppressor SASH1 Interacts With the Signal Adaptor CRKL to Inhibit Epithelial-Mesenchymal Transition and Metastasis in Colorectal Cancer.Cellular and molecular gastroenterology and hepatology · 2019Article
- p53 regulates ERK1/2/CREB cascade via a novel SASH1/MAP2K2 crosstalk to induce hyperpigmentation.Journal of cellular and molecular medicine · 2017Article
- A novel P53/POMC/Gαs/SASH1 autoregulatory feedback loop activates mutated SASH1 to cause pathologic hyperpigmentation.Journal of cellular and molecular medicine · 2017Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
17 authors.
Yiqun G ShellmanDepartment of Dermatology, School of Medicine, University of Colorado Anschutz Medical Campus, Aurora, Colorado, USA. Electronic address: Yiqun.Shellman@ucdenver.edu.
Karoline A LambertDepartment of Dermatology, School of Medicine, University of Colorado Anschutz Medical Campus, Aurora, Colorado, USA.
Anne BrauweilerDepartment of Dermatology, School of Medicine, University of Colorado Anschutz Medical Campus, Aurora, Colorado, USA.
Pamela FainHuman Medical Genetics and Genomics Program, School of Medicine, University of Colorado Anschutz Medical Campus, Aurora, Colorado, USA; Barbara Davis Center for Childhood Diabetes, School of Medicine, University of Colorado Anschutz Medical Campus, Aurora, Colorado, USA.
Richard A SpritzHuman Medical Genetics and Genomics Program, School of Medicine, University of Colorado Anschutz Medical Campus, Aurora, Colorado, USA.
Melanie MartiniDepartment of Surgery, Klinikum rechts der Isar, Technische Universität München, Munich, Germany.
Klaus-Peter JanssenDepartment of Surgery, Klinikum rechts der Isar, Technische Universität München, Munich, Germany.
Neil F BoxCharles C. Gates Regenerative Medicine and Stem Cell Biology Program, Department of Dermatology, School of Medicine, University of Colorado Anschutz Medical Campus, Aurora, Colorado, USA.
Tamara TerzianCharles C. Gates Regenerative Medicine and Stem Cell Biology Program, Department of Dermatology, School of Medicine, University of Colorado Anschutz Medical Campus, Aurora, Colorado, USA.
Marian RewersBarbara Davis Center for Childhood Diabetes, School of Medicine, University of Colorado Anschutz Medical Campus, Aurora, Colorado, USA.
Anelia HorvathSection on Endocrinology and Genetics, Program on Developmental Endocrinology and Genetics, Eunice Kenney Shriver National Institute of Child Health and Human Development (NICHD), National Institutes of Health (NIH), Bethesda, Maryland, USA.
Constantine A StratakisSection on Endocrinology and Genetics, Program on Developmental Endocrinology and Genetics, Eunice Kenney Shriver National Institute of Child Health and Human Development (NICHD), National Institutes of Health (NIH), Bethesda, Maryland, USA.
William A RobinsonDivision of Medical Oncology, School of Medicine, University of Colorado Anschutz Medical Campus, Aurora, Colorado, USA.
Steven E RobinsonDivision of Medical Oncology, School of Medicine, University of Colorado Anschutz Medical Campus, Aurora, Colorado, USA.
David A NorrisDepartment of Dermatology, School of Medicine, University of Colorado Anschutz Medical Campus, Aurora, Colorado, USA.
Kristin B ArtingerDepartment of Craniofacial Biology, University of Colorado School of Dental Medicine, Aurora, Colorado, USA.
Theresa R PachecoDepartment of Dermatology, School of Medicine, University of Colorado Anschutz Medical Campus, Aurora, Colorado, USA. Electronic address: Theresa.Pacheco@ucdenver.edu.
Funding
University of Colorado Cancer Center Support Grant - Lung Cancer Patient-Derived Xenografts with Autologous Human Immune SystemsP30CA046934 · NCI · UNIVERSITY OF COLORADO DENVER · PI James V Degregori · 1988 to 2026
$117.0MColorado Clinical and Translational Sciences InstituteUL1TR001082 · NCATS · UNIVERSITY OF COLORADO DENVER · PI SOKOL, RONALD J. · 2013 to 2017
$48.0MMolecular Genetics of Endocrine Tumors and Related DisordersZIAHD008920 · NICHD · EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT · PI STRATAKIS, CONSTANTINE A. · 2012 to 2021
$25.8MTransgenic and Gene Targeting CoreP30AR057212 · NIAMS · UNIVERSITY OF COLORADO DENVER · PI SPRITZ, RICHARD ANDREW · 2009 to 2018
$6.2MTraining in Translational Research of Skin DiseasesT32AR007411 · NIAMS · UNIVERSITY OF COLORADO DENVER · PI ASGARI, MARYAM MANDANA, ROOP, DENNIS · 1986 to 2025
$4.8MClinical Basis Investigations into MLS/Leopard SyndromeK23AR049214 · NIAMS · UNIVERSITY OF COLORADO DENVER · PI PACHECO, THERESA R · 2003 to 2007
$653kTargeting p53-Dependent Repigmentation in VitiligoK01AR063203 · NIAMS · UNIVERSITY OF COLORADO DENVER · PI TERZIAN, TAMARA G · 2012 to 2016
$503kThe role of keratinocyte p53 in development of pigmented lesionsR03AR066880 · NIAMS · UNIVERSITY OF COLORADO DENVER · PI BOX, NEIL FREDERICK · 2015 to 2017
$233kThe role of SASH1 in skin pigmentationR03AR064555 · NIAMS · UNIVERSITY OF COLORADO DENVER · PI SHELLMAN, YIQUN G · 2014 to 2016
$233kNCATS NIH HHS UL1 TR001082NCI NIH HHS P30 CA046934NCI NIH HHS P30CA046934NIAMS NIH HHS K01 AR063203NIAMS NIH HHS K23 AR049214NIAMS NIH HHS K23AR49214NIAMS NIH HHS P30 AR057212NIAMS NIH HHS P30AR057212NIAMS NIH HHS R03 AR064555NIAMS NIH HHS R03AR064555NIAMS NIH HHS R03 AR066880NIAMS NIH HHS T32 AR007411NIAMS NIH HHS T32AR007411
Abstract
PubMed holds no abstract for this paper.
Indexed as
Genetic LinkageHumansLentigoPhenotypeTumor Suppressor ProteinsSASH1 protein, humanTumor Suppressor Proteins
Identifiers
What OpenQuestion holds
Textmetadata
LicenceTDM
Read underepoch 390
Registered trials
None linked
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.